Small cap round-up: Angel Biotechnology, Glanbia, MBL Group
Angel Biotechnology has signed an agreement with arGentis Pharmaceuticals that could see it manufacture the firm's ARG201 drug, a treatment for the life-threatening autoimmune disease, systemic sclerosis. Angel's stock rose 6.6% in morning trading.
Angel Biotechnology has signed an agreement with arGentis Pharmaceuticals that could see it manufacture the firm's ARG201 drug, a treatment for the life-threatening autoimmune disease, systemic sclerosis. Angel's stock rose 6.6% in morning trading.
Glanbia, a nutritional solutions and cheese maker, has announced plans to enter a joint venture to incorporate the business and assets of Dairy Ingredients Ireland. The business is the largest dairy ingredients processor in Ireland, assembling a milk pool of 1.6bn litres and processing it into around 180,000 tonnes of ingredients, largely for export. The group also reported first half results on Wednesday showing pre-tax profits up 24% on the prior year. Glanbia's shares were up 4% at 11:28.
MBL Group, an audio and visual entertainment distributor, appears to be clawing its way back to health after losing its most important customer, Morrisons, last year. In its full year results to the end of March, revenues dropped massively, from £195.3m to £28.1m. Revenue from continuing operations dropped from £20m to £17.7 while the loss before tax came in at £2.1m (from discontinued operations this figure was £8.8m). Group loss per share was 40.8p. Nevertheless, MBL is free from debt and has cash balances of £4.0m and a headcount down 75%. This was enough to boost the stock 8% in morning trading.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
BS
-
FTSE 100 hits record highs – why is it rising and will we see more gains?
Advice UK equities have been described as unloved for a long time but as the FTSE 100 hits new highs, we explain if now is the time to buy British.
By Marc Shoffman Published
-
How to invest in copper
It may be time to invest in copper as the red metal appears poised for a big jump. Dominic Frisby looks at what should investors should buy
By Dominic Frisby Published